The impact of CGRP monoclonal antibodies on cytokine expression in chronic migraine: a cohort study
In this study of patients with chronic migraine, we found no evidence that treatment with CGRP mABs is associated with a significant alteration in plasma cytokine levels or shift to a Th1 phenotype.
Authors
- Manjit Singh Matharu (ORCID: https://orcid.org/0000-0002-4960-2294)
- Helmut Butzkueven (ORCID: https://orcid.org/0000-0003-3940-8727)
- Elspeth Hutton (ORCID: https://orcid.org/0000-0002-8543-7767)
- Jason C. Ray (ORCID: https://orcid.org/0000-0003-4833-5507)
- Wei Zhen Yeh (ORCID: https://orcid.org/0000-0002-5335-6612)
- Stuart J. McDonald (ORCID: https://orcid.org/0000-0001-5190-3179)
- Marian Todaro (ORCID: https://orcid.org/0000-0003-0190-5760)
- Josephine Baker
Institutions
- Monash Alfred Psychiatry Research centre (AU)
- Monash Health (AU)
- National Hospital for Neurology and Neurosurgery (GB)
- Alfred Health (AU)
- Austin Health (AU)
- University College London (GB)
- Monash University (AU)
Publication Details
- Journal
- Journal of Neurology
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1007/s00415-025-13400-w
- Citations
- 1
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47